APOE and Parkinson disease: We found that while ApoE ε4-carriers had a higher prevalence of dementia than non-carriers among PD patients, ApoE ε4 was associated with a statistically significant lower risk of PD (OR: 0.75, 95%CI: 0.59-0.94) [19].